338 related articles for article (PubMed ID: 20887681)
1. Induced pluripotent stem (iPS) cell research overview.
Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
[TBL] [Abstract][Full Text] [Related]
2. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
Cheng D; Lei L; Lu Z; Li Z; Wang H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
[TBL] [Abstract][Full Text] [Related]
3. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
5. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
6. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
7. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
9. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
11. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells.
Cai H; Xia X; Wang L; Liu Y; He Z; Guo Q; Xu C
Biochem Biophys Res Commun; 2013 Apr; 433(3):286-91. PubMed ID: 23524261
[TBL] [Abstract][Full Text] [Related]
13. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
Kaichi S; Hasegawa K; Takaya T; Yokoo N; Mima T; Kawamura T; Morimoto T; Ono K; Baba S; Doi H; Yamanaka S; Nakahata T; Heike T
Cardiovasc Res; 2010 Nov; 88(2):314-23. PubMed ID: 20547733
[TBL] [Abstract][Full Text] [Related]
14. Emerging methods for preparing iPS cells.
Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
[TBL] [Abstract][Full Text] [Related]
15. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
16. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells.
Zaehres H; Kim JB; Schöler HR
Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
[TBL] [Abstract][Full Text] [Related]
18. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
[TBL] [Abstract][Full Text] [Related]
19. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
[TBL] [Abstract][Full Text] [Related]
20. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
Meissner A; Wernig M; Jaenisch R
Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
